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Abstract
Objectives. To describe conservative and surgical foot care in patients with RA in England and explore
factors that predict the type of foot care received.
Methods. Use of podiatry and type of foot surgery were outcomes recorded in an inception cohort
involving nine rheumatology centres that recruited patients with RA between 1986 and 1998 across
England. Associations between patient-specific factors and service use were identified using univariate
logistic regression analyses. The independence of these associations was then verified through multiple
binary logistic regression modelling.
Results. Data were collected on 1237 patients with RA [66.9% females, mean (S.D.) age at disease
onset=54.36 (14.18) years, median DAS=4.09 (1st quartile=3.04, 3rd quartile=5.26), median HAQ=1
(0.50,1.63)]. Interventions involving the feet in the cohort were low with only 364 (30%) out of 1218
receiving podiatry and 47 (4%) out of 1237 patients having surgery. At baseline, female gender, increasing
age at onset, being RF positive and higher DAS scores were each independently associated with
increased odds of seeing a podiatrist. Gender, age of onset and baseline DAS were independently
associated with the odds of having foot surgery.
Conclusions. Despite the known high prevalence of foot pathologies in RA, only one-third of this cohort
accessed podiatry. While older females were more likely to access podiatry care and younger patients
surgery, the majority of the RA population did not access any foot care.
Key words: Rheumatoid arthritis, Foot, Podiatry, Surgery, Orthopaedic surgery, Foot care, Access to service.
Introduction
The propensity of RA to affect the joints of the hands
and feet is familiar to patients and clinicians alike. Foot
symptoms account for the initial presentation in 20% of
patients, increasing with disease duration to eventually
affect 90% of patients during the course of their
disease [13].
Repeated and chronic inflammatory changes of the
joints and periarticular tissues result in important and irre-
versible structural changes [46]. The usual forefoot pres-
entation is of retraction and dorsal subluxation of the
lesser toes, displacement of the plantar fat pad and par-
ticularly hallux valgus, which has been reported in 80% of
patients with established disease [7, 8]. Involvement of the
mid- and rear-foot is less common initially, but manifests
as tibialis posterior tendon dysfunction, flattening of the
medial longitudinal arch and valgus deformity of the
calcaneus [5, 9].
In addition to physical deformity, patients with RA can
endure neurological and vascular deficiency in their feet,
which contributes to impaired tissue viability and ulcer-
ation [1013]. Furthermore, there is a growing body of
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foot have subsequent global impact on physical function,
emotional well-being and quality of life in patients with
RA [1416].
Evidence for conservative treatment of foot pathology
exists through randomized controlled trials that demon-
strate the effectiveness of interventions including foot
orthoses and specialist footwear in improving pain and
foot-related quality of life in patients with RA [17, 18]. In
comparison, however, despite some evidence from ob-
servational studies, there is a paucity of quality evidence
for the effectiveness of foot surgery in RA [19, 20].
Foot health services, particularly conservative care,
may be provided by a variety of health professionals
with some overlap between, for example, orthotists and
podiatrists in the provision of this care. Despite this diver-
sity, clinicians have expressed concerns as to the gener-
ally poor availability of foot health services across
rheumatology [21, 22]. National surveys have identified
large regional variation in provision of foot care resulting
in suboptimal care [22]. In 2006, only one-quarter
of rheumatology departments reported having access to
a podiatrist and only 18% had foot health services dedi-
cated to rheumatology [22]. This inadequacy of foot health
service provision on the NHS has led to as few as 40% of
rheumatology patients receiving any foot care, half of
whom had to purchase it privately [23].
To date, the only national study looking at foot health
provision found large variation between regions [22]. Yet
the only study looking at patients’ use of foot health
services in rheumatology investigates this in a single
hospital [23]. To date, no study has investigated the use
of foot heath services on a national level specifically in RA.
The aim of this study was to describe foot care, including
foot surgery, in patients with RA from a national perspec-
tive and to explore factors that predict the type of foot
care received.
Methods
Participants
The Early Rheumatoid Arthritis Study (ERAS) is an incep-
tion cohort still in follow-up, which recruited patients
between 1986 and 1998, from nine hospitals across
England. Ethical approval was gained from the East
Hertfordshire Ethics Committee. Consecutive assenting
patients with RA were enrolled if symptoms had been pre-
sent for <2 years and before initiation of DMARD therapy.
Patients not meeting the 1987 ACR criteria [24] were
followed up and subjected to subgroup analysis with
patients being excluded if the diagnosis changed—for
example, early RA changing to lupus. Further information
regarding entry criteria and follow-up details has been
described in previous reports [25, 26].
All centres followed the UK published framework guide-
lines for management of RA in the 1990s, which include
early use of sequential monotherapy, step-up combin-
ation therapy in patients with severe disease and judicious
use of steroids. DMARDs were chosen according to the
physician’s preference, with SSZ the most commonly
used first DMARD followed by MTX, as previously descr-
ibed. Biological agents were not used during the study
period.
Data collection
Prospective standardized clinical and laboratory assess-
ments were performed by trained metrologists at initial
presentation and at an annual appointment. These
included two articular indices; the Ritchie articular index
(RAI) and a swollen joint count (SJC) of 59 joints, as
described previously [26], HAQ, a 100-mm visual ana-
logue scale for pain and presence of extra-articular fea-
tures and nodules. Disease activity was measured using
the original three-variable disease activity score (DAS)
based on tender joint count and SJC and acute-phase
marker (ESR or CRP) as this was the main tool available
at the time [27]. Standardized radiographs of the hands
and feet taken at presentation and at 1, 2, 3, 5, 7 and
9 years were digitized, and then scored by one observer
as reported previously [28]. Social deprivation was mea-
sured using the Carstairs deprivation index with scores
derived from results of the 1991 census. Laboratory vari-
ables included ESR and presence of RF. Allied health pro-
fessional (AHP) intervention (podiatrist and orthotist) along
with provision of aids and appliances (walking aids) were
recorded except where these were issued in the immedi-
ate post-operative period. Each inpatient episode was
documented along with details of soft tissue, tendon or
joint surgery resulting from RA as previously reported [29].
Full details of clinical and laboratory assessments em-
ployed in the cohort are described elsewhere [25, 26].
Statistical analysis
Summary statistics were used to describe clinical features
of the cohort along with use of conservative foot health
intervention provided by podiatrists and orthotists up to
9 years after diagnosis. Exploratory analysis was performed
to identify patient-specific factors associated with use of
podiatry and surgery. For podiatry, odds ratios (ORs) were
calculated separately for each independent variable using
bivariate logistic regression analyses, and then the inde-
pendence of these associations were verified through
multiple binary logistic regression modelling. Wald tests
were used to assess the significance of the association
between each predictor and the odds of the outcome.
Pearson’s residuals and leverage values were inspected
to identify any potential outliers. Hosmer and Lemeshow
tests were used to assess goodness-of-fit and the re-
ceiver operating characteristic (ROC) area under the
curve was used as an indicator of the discriminatory
power of each model. For surgery (where more accurate
data were available regarding the timing of the interven-
tion), Cox proportional hazard regression analyses were
conducted for variables recorded at entry into the study
and at 1 year; variables recorded at any time during
follow-up were entered into binary logistic regression
models as for podiatry. For Cox regression, the proportion-
al hazards assumption was tested for individual variables
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test of nested models, one of which contained a full set of
interactions between all of the entered variables and log
(time to surgery). Goodness-of-fit was assessed using the
Groennesby and Borgan test. Statistical analyses were
conducted in PASW 17.0.2 and Stata 11. Full data were
not available for all patients, but because the proportion of
patients with missing data was low (<6%), we chose to
include only patients with data available at each stage of
the analysis and did not impute any missing values.
Results
The sample consisted of 1237 patients, of whom 33.1%
(n=409) were male and 66.9% (n=828) were female. The
mean (S.D.) age at onset of symptoms was 54.36 (14.18)
years with a range of 1793 years. The median [interquar-
tile range (IQR)] baseline DAS and HAQ were 4.09
(3.045.26) and 1.000 (0.5001.625), respectively. RF
was not available at baseline for 14 patients; 899
(73.5%) out of 1223 were at least weakly RF positive
and 770 (62.9%) out of 1223 were moderately or strongly
RF positive. Erosions were present in a minority of pa-
tients [302 (24.9%) out of 1212] at baseline [feet 122
(10.1%) out of 1212; hands 86 (7.1%) out of 1212;
hands and feet 94 (7.8%) out of 1212].
One year afterdiagnosis,both the median(IQR) DASand
HAQ had reduced to 2.97 (1.854.11) and 0.625
(0.1251.375), respectively. However, the number of pa-
tients with any erosions had increased [412 (38%) out
of 1075], as did the number with foot erosions [290 (27%)
out of 1075]. Data on the Carstairs deprivation index were
available for 1231 patients: proportions of patients falling
into the five quintiles were 18.2% (lowest quintile), and
21.9, 24.4, 18.0 and 17.1% (highest quintile). Maximum
follow-up for conservative care varied, with 57% (n=702)
followed up for 9 years, 92% (n=1142) for 5 years
and 100% (n=1237) for 3 years. At maximum follow-up,
82%(n=1012)hadbeenRFpositiveatsomepointoftheir-
disease, 79% (n=974) had ever had erosions detected on
X-ray and 34% (n=425) had ever had nodules.
Patients who were lost to follow-up or died before their
9-year follow-up did not differ substantively from those
who were followed up in terms of age at onset (mean
56 vs 53 years), gender (both groups 67% females), base-
line DAS (mean 4.2 vs 4.3), baseline HAQ (median 1.125 vs
1.000), RF-positive status (72 vs 75%), presence of ero-
sions at baseline (16 vs 19%) or Carstairs deprivation
index (lowest or second quintile 38 vs 42%; fourth or
highest quintile 36 vs 34%).
Although 827 (68.9%) out of 1201 used assistive appli-
ances during the study period (e.g. wrist splints, kitchen
aids, etc.), only 20 patients reported using a walking aid or
caliper, and hence this number was too small for mean-
ingful further analysis. However, 190 (15.5%) out of 1225
patients were seen by an orthotist during the follow-up
period and associations with use of podiatry and use of
surgery were explored.
Data on podiatry input were available for 1218 patients,
of whom only 30% (n=364) received podiatry care
following inception. The proportion of patients seeing a
podiatrist increased with time despite the absolute num-
bers falling due to incomplete data. At 3 years, 17.4%
(n=200/1152) had seen a podiatrist; by 5 years the pro-
portion was 26.1% (n=266/1021) and had risen to 36.5%
(n=251/687) by 9 years.
A total of 59 surgical procedures were performed on
47 (4%) patients; the mean (S.D.) age of patients at their
first operation was 53.6 (12.8) years. The time to patients
having their first operation ranged from 7 to 106 months,
with a median (first to third quartile) of 58 (4179) months.
The vast majority of procedures were conducted on the
forefoot with 41 MTP joint procedures on 32 patients
compared with 4 on the ankle or hindfoot of 4 patients
and 14 soft-tissue procedures on 12 patients. Range
of movement (ROM) data were dichotomized for each of
theavailableanatomicallocationsaseitherreducedornor-
mal. Reduced ROM was seen in 33.0% (n=359/1087) of
patients at their MTP joints, 37.6% (n=426/1133) of pa-
tients in their hindfoot and 36.8% (n=418/1135) of patient
at their ankles.
Associations of patient-specific factors with use of
podiatry and surgery
Results of all bivariate analyses showing associations with
use of podiatry and foot surgery are summarized below
and presented in Table 1 (supplementary details of the lo-
gistic regression analyses are presented in appendix A,
available as supplementary data at Rheumatology Online).
Use of podiatry
Bivariate analyses revealed associations between several
demographic factors and use of podiatry (Table 1). The
mean (S.D.) age at onset of the group who had ever
received podiatry was 59.10 (13.0) years, whereas those
who did not receive podiatry were younger with a mean
(S.D.) age of 52.21 (14.2) years. Unadjusted odds of receiv-
ing podiatry increased with age, and were higher in
females than males. No association was identified
between social deprivation and use of podiatry.
Markers of disease severity were examined and found
to be inconsistently associated with future podiatric care.
There were no substantive associations with the presence
of nodules or RF at baseline or 1 year. However, the pres-
ence of erosions in the hands or feet at either time point
increased the odds of accessing podiatry as did higher
ESR, DAS and HAQ.
Patients who saw an orthotist at any point during the
follow-up period were also more likely to see a podiatrist
(OR 4.33). There was some evidence that recording a
positive RF at any point during follow-up was associated
with higher odds of podiatry (OR 1.32), but this was not
statistically significant at the 5% level (P=0.093). Patients
with reduced ROM in their feet during the follow-up period
were more likely to be treated by podiatrists. Reduced
hindfoot ROM was most strongly associated with podiatry
(OR 2.71, P<0.001) closely followed by impairment of the
MTP joints (OR 2.68, P<0.001) and ankle (OR 2.35,
P<0.001).
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At baseline n
n (%) had
podiatry ever OR (95% CI)
Significance
(P-value)
Gender
Male 404 75 (18.6) 2.415 (1.809, 3.224) <0.001
Female 814 289 (35.5)
Age at onset, per year 1218  1.038 (1.028, 1.047) <0.001
Carstairs deprivation index
First quintile 221 70 (31.7) Reference, overall 0.223
Second quintile 267 80 (30.0) 0.923 (0.627, 1.357) 0.683
Third quintile 296 79 (26.7) 0.785 (0.535, 1.152) 0.216
Fourth quintile 217 77 (35.5) 1.186 (0.798, 1.765) 0.399
Fifth quintile 206 56 (27.2) 0.805 (0.530, 1.223) 0.310
RF
Negative 322 89 (27.6) 1.167 (0.880, 1.549) 0.284
Positive 882 272 (30.8)
Nodules
Absent 1123 335 (29.8) 1.034 (0.656, 1.629) 0.887
Present 95 29 (30.5)
X-ray erosions foot only
Absent 984 284(28.9) 1.250 (0.910, 1.716) 0.168
Present 211 71 (33.6)
X-ray erosions hands or feet
Absent 900 252 (28.0) 1.379 (1.042, 1.825) 0.024
Present 295 103 (34.9)
ESR, per mm/h 1216  1.006 (1.002, 1.010) 0.006
DAS, per unit 1209  1.180 (1.094, 1.273) <0.001
HAQ, per unit 1212  1.571 (1.334, 1.850) <0.001
At 1 year n
n (%) had
podiatry ever OR (95% CI)
Significance
(P-value)
Nodules
Absent 1095 323 (29.5) 1.195 (0.804, 1.777) 0.379
Present 123 41 (33.3)
X-ray erosions foot only
Absent 776 207 (26.7) 1.530 (1.147, 2.043) 0.004
Present 288 103 (35.8)
X-ray erosions hands or feet
Absent 654 175 (26.8) 1.344 (1.027,1.759) 0.031
Present 410 135 (32.9)
ESR, per mm/h 1178  1.009 (1.005, 1.014) 0.001
DAS, per unit 1170  1.226 (1.137,1.323) <0.001
HAQ, per unit 1182  1.742 (1.475, 2.058) <0.001
Ever during follow-up n
n (%) had
podiatry ever OR (95% CI)
Significance
(P-value)
Saw an orthotist
No 1029 253 (24.6) 4.326 (3.132, 5.974) <0.001
Yes 188 110 (58.5)
RF
Negative 221 56 (25.3) 1.323 (0.950, 1.843) 0.098
Positive 994 308 (31.0)
Nodules
Absent 798 228 (28.6) 1.197 (0.927, 1.546) 0.168
Present 420 136 (32.4)
X-ray erosions hands or feet
Absent 252 60 (23.8) 1.467 (1.065, 2.020) 0.019
Present 964 303 (31.4)
Hindfoot ROM
Normal 694 150 (21.6) 2.713 (2.083, 3.533) <0.001
Reduced 423 181 (42.8)
MTP joint ROM
Normal 717 165 (23.0) 2.683 (2.044, 3.522) <0.001
Reduced 355 158 (44.5)
Ankle ROM
Normal 705 161 (22.8) 2.354 (1.809, 3.063) <0.001
Reduced 414 170 (41.1)
(continued)
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At baseline n
Mean (95% CI) time
to foot surgery HR (95% CI)
Significance
(P-value)
Gender
Male 409 106.72 (105.80, 107.64) 2.481 (1.159, 5.308) 0.010
Female 828 105.13 (104.19, 106.06)
Age of onset, per year 1237  0.974 (0.954, 0.994) 0.012
Carstairs deprivation index
First quintile 224 105.81 (104.36, 107.26) Reference, overall 0.754
Second quintile 270 106.49 (105.28, 107.69) 0.654 (0.243, 1.756) 0.654
Third quintile 300 105.69 (104.28, 107.10) 0.958 (0.397, 2.312) 0.958
Fourth quintile 221 105.83 (104.26, 107.39) 0.915 (0.353, 2.371) 0.854
Fifth quintile 211 104.71 (102.59, 106.43) 1.268 (0.515, 3.120) 0.606
RF
Negative 222 106.02 (104.73, 107.30) 1.148 (0.584, 2.254) 0.686
Positive 1012 105.51 (104.67, 106.34)
Nodule
Absent 812 105.61 (104.88, 106.35) 0.752 (0.233, 2.422) 0.618
Present 425 106.14 (103.96, 108.31)
X-ray erosions foot only
Absent 996 106.00 (105.29, 106.71) 1.648 (0.851, 3.190) 0.155
Present 216 104.58 (102.58, 106.59)
X-ray erosions hands or feet
Absent 910 106.02 (105.28, 106.76) 1.550 (0.834, 2.880) 0.178
Present 302 104.91 (103.29, 106.52)
Baseline ESR 1235  0.998 (0.988, 1.008) 0.710
Baseline DAS 1227  1.229 (1.041, 1.450) 0.015
HAQ, per unit 1231  0.893 (0.667, 1.448) 0.932
At 1 year n
Mean (95% CI) time
to foot surgery OR (95% CI),
Significance
(P-value)
Nodules
Absent 1111
a 93.83 (93.13, 94.54) 1.252 (0.531, 2.953) 0.608
Present 125 92.94 (90.50, 95.38)
X-ray erosions foot only
Absent 784
a 94.22 (93.45, 94.98) 1.984 (1.053, 3.736) 0.034
Present 290 92.74 (91.09, 94.39)
X-ray erosions hands or feet
Absent 662
a 94.04 (93.18, 94.90) 1.375 (0.733, 2.580) 0.322
Present 412 93.41 (92.13-94.68)
ESR, per mm/h 1194
a  1.010 (0.999, 1.020) 0.085
DAS, per unit 1186
a  1.161 (0.979, 1.377) 0.085
HAQ, per unit 1198
a  0.989 (0.662, 1.477) 0.957
Ever during follow-up n
n (%) had
foot surgery OR (95% CI)
Significance
(P-value)
Saw an orthotist
No 1035 25 (2.4) 5.290 (2.916, 9.599) <0.001
Yes 190 22 (11.6)
RF
Negative 222 7 (3.2) 1.264 (0.559, 2.860) 0.573
Positive 1012 40 (4.0)
Nodules
Absent 812 24 (3.0) 1.879 (1.047, 3.370) 0.032
Present 425 23 (5.4)
X-ray erosions hands or feet
Absent 261 6 (2.3) 1.868 (0.784, 4.448) 0.152
Present 974 41 (4.2)
Hindfoot ROM
Normal 707 23 (3.3) 1.542 (0.843, 2.822) 0.157
Reduced 426 21 (4.9)
MTP joint ROM
Normal 728 18 (2.5) 2.952 (1.589, 5.487) <0.001
Reduced 359 25 (7.0)
Ankle ROM
Normal 717 24 (3.3) 1.451 (0.792, 2.660) 0.226
Reduced 418 20 (4.8)
aOne patient who had soft-tissue surgery within the first 12 months was excluded from ‘any surgery’ and ‘soft-tissue surgery’
1-year analyses because this would confound the predictive model.
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The mean (S.D.) age at onset of the group recorded as ever
having foot surgery was 48.70 (12.61) years, whereas
those who did not have surgery were older with a mean
(S.D.) age of onset of 54.58 (14.20) years. Age of onset of
RA was associated with having foot surgery with the
hazard (risk) of having surgery decreasing by 2.6% per
year of age at disease onset (P=0.012). As with use of
podiatry, females were more than twice as likely to have
foot surgery within the given observation period com-
pared with males [hazard ratio (HR) 2.48, P=0.010],
although the 95% CI (1.16, 5.31) was wider due to the
small number of patients having surgery.
Investigation of associations between markers of dis-
ease severity and foot surgery revealed that baseline
DAS demonstrated a strength of association with any
foot surgery similar to that with the use of podiatry (HR
1.23 for each unit increase in DAS, P=0.015). In contrast,
baseline ESR and HAQ at baseline were not significantly
associated with foot surgery. Furthermore, by 1 year, nei-
ther ESR, DAS nor HAQ was associated with future foot
surgery. Patients having foot surgery were also more likely
to receive care from an orthotist (OR 5.29, P<0.001).
However, out of the 47 patients who had foot surgery,
28 of them had not seen a podiatrist in the first 9 years
of their disease, and 18 had seen neither a podiatrist nor
an orthotist.
Predictors of future podiatry and foot surgery
Multivariate logistic and Cox regression models were con-
structed to predict future use of podiatry and any foot
surgery using variables available at inception to the
cohort, or at 1 year. Age at onset, gender, Carstairs de-
privation index, baseline RF, presence of erosions in the
hands or feet (at baseline or 1 year), DAS (at baseline or
1 year) and HAQ (at baseline or 1 year) were entered into
the models exploring podiatry. ESR was included in the
DAS, and X-ray erosions in the feet and erosion in hands
or feet were collinear; therefore, only DAS and erosions in
feet were entered into the models. Values for age at onset
and baseline DAS and HAQ were centred on the means of
their distributions. Data on ROM and whether patients
saw an orthotist were not available at baseline or 1 year;
because they were likely to change throughout the dis-
ease course they were not entered into the models.
Since only a small number of patients had foot surgery,
only variables that were individually associated with the
outcome at the 20% significance level (sex, age at onset,
X-ray erosions in the feet and baseline DAS) were entered
into the surgery model. While this approach risks exclud-
ing variables that might have emerged as significant con-
tributors to the multivariate model, this was preferable to
biasing the results by including too many predictors as
this can destabilize the model and/or lead to inaccurate
coefficient estimates.
When all of the putative predictors were entered into the
podiatry model simultaneously, female gender, increasing
age at onset, being RF positive and increasing baseline
DAS were each independently associated with increased
odds of seeing a podiatrist. Results for a parsimonious
model containing only these significant predictors are pre-
sented in Table 2. There was no evidence of interactions
between the predictors. This model was a statistically ad-
equate fit to the observed data (Hosmer and Lemeshow
goodness-of-fit P=0.313), but it did not have substantial
discriminatory power [area under the ROC curve (95%
CI)=0.70 (0.67, 0.73)]. Adjusting for the duration of
follow-up slightly improved the discriminatory power of
the model [0.73 (0.70, 0.76)] because those with longer
follow-up were more likely to see a podiatrist, but the
addition of this term to the model did not substantively
alter the ORs for the existing predictors, consequently
the ORs presented have not been adjusted for duration
of follow-up.
At 1 year, gender, age at onset and DAS remained in the
model (Table 2). RF was no longer independently asso-
ciated with podiatry, but the presence of erosions in the
feet at 1 year was associated with an increase in the odds
of seeing a podiatrist. HAQ was not found to be asso-
ciated with the odds of podiatry at baseline, but at
1 year showed evidence of being associated with subse-
quent podiatry use. The 1-year model did not have sub-
stantially greater discriminatory power than the baseline
model.
At baseline, female gender, younger age at onset and
DAS were each independently associated with the risk of
having any sort of foot surgery (Table 3). Full data for this
model were available for 1227 patients, 47 of whom had
surgery during the follow-up period. There was no evi-
dence of any interactions between the predictors. For
this model, the proportional hazards assumption held (all
individual variables P>0.05, overall model P=0.902) and
the fit statistics were adequate (Groennesby and Borgan
goodness-of-fit P=0.263), but the C-index did not indi-
cate substantial discriminatory power (C=0.67).
At 1 year, female gender and younger age at onset were
associated with the risk of having foot surgery, but DAS at
1 year was not associated with subsequent foot surgery
(OR 1.099, P=0.348). Although the presence of erosions
in the feet at baseline was not strongly associated (OR
1.684, P=0.112) by 1 year, foot erosions were associated
with an increase in the risk of having foot surgery within
the follow-up period. Full data for the model containing
gender, age and foot erosions at 1 year were available
for 1075 patients, 39 of whom had surgery during the
follow-up period. For this model, the proportional hazards
assumption held (all individual variables P>0.05, overall
model P=0.656) and the fit statistics were adequate
(Groennesby and Borgan goodness-of-fit P=0.871), but
the C-index did not indicate substantial discriminatory
power (C=0.70).
Discussion
This study is the first to describe on a national level the
use of foot care including foot surgery in a multicentre
cohort of patients with RA. It has identified low levels of
both conservative and surgical foot care over the first
9 years of treatment. This study has also identified
www.rheumatology.oxfordjournals.org 1591
Use of conservative and surgical foot care in RApatient-specific factors at disease onset that are then
associated with subsequent conservative and surgical
foot care and attempts to differentiate between the two.
Patients with higher disease activity at onset were more
likely to receive foot surgery or conservative therapy.
However, older female patients were more likely to have
TABLE 3 Multivariate Cox proportional hazard regression models for baseline and 1 year predictors of foot surgery
B SE Wald P-value HR (95% CI)
Baseline (n=1227)
Variable
Gender: female 0.801 0.391 4.20 0.040 2.228 (1.036, 4.793)
Age of onset, per unit 0.024 0.010 5.51 0.019 0.976 (0.957, 0.996)
Baseline DAS, per unit 0.213 0.085 6.34 0.012 1.238 (1.048, 1.461)
Model performance  
2,d f
Overall model evaluation: likelihood ratio test 17.46, 3 0.001
Proportional hazards assumption: likelihood ratio test 0.58, 3 0.902
Goodness-of-fit: Groennesby and Borgan score test 6.48, 5 0.263
Discrimination
Harrell’s concordance (C) 0.67
1 year (n=1074)
Variable
Gender: female 1.461 0.530 7.608 0.006 4.311 (1.526, 12.175)
Age of onset, per unit 0.028 0.011 6.113 0.013 0.973 (0.951, 0.994)
1 year erosions present in feet 0.664 0.323 4.220 0.040 1.943 (1.031, 3.662)
Model performance  
2,d f
Overall model evaluation: likelihood ratio test 23.15, 3 <0.001
Proportional hazards assumption: likelihood ratio test 1.62, 3 0.656
Goodness-of-fit: Groennesby and Borgan score test 1.83, 5 0.871
Discrimination
Harrell’s concordance (C) 0.70
TABLE 2 Multivariate logistic regression models for baseline and 1 year predictors of podiatry
B SE Wald P-value OR 95% CI
Baseline (n=1196)
Variable
Gender: female 1.018 0.155 43.39 <0.001 2.768 (2.045, 3.748)
Age of onset, per unit 0.038 0.005 58.83 <0.001 1.039 (1.029, 1.049)
RF positive 0.258 0.153 2.85 0.091 1.294 (0.960, 1.745)
Baseline DAS, per unit 0.141 0.041 11.78 0.001 1.151 (1.062, 1.247)
Constant 1.831 0.179 105.12 <0.001 0.160 (NA)
Model performance  
2,d f
Overall model evaluation: likelihood ratio test 122.46, 4 <0.001
Goodness-of-fit test: Hosmer and Lemeshow 9.36, 8 0.313
Discrimination
Area under the ROC curve (SE) 0.70 (0.02) <0.001
1 year (n=1168)
Variable
Gender: female 0.906 0.169 28.75 <0.001 2.474 (1.776, 3.445)
Age of onset, per unit 0.039 0.006 49.00 <0.001 1.040 (1.028, 1.051)
1 year erosions present in feet 0.472 0.159 8.78 0.003 1.603 (1.173, 2.190)
1 year DAS, per unit 0.105 0.056 3.55 0.059 1.110 (0.996, 1.238)
1 year HAQ, per unit 0.257 0.121 4.54 0.033 1.293 (1.021, 1.638)
Constant 0.743 0.156 124.11 <0.001 0.175 (NA)
Test  
2,d f
Overall model evaluation: likelihood ratio test 127.19, 5 <0.001
Goodness-of-fit test: Hosmer and Lemeshow 5.37, 8 0.718
Discrimination
Area under the ROC curve (SE) 0.72 (0.02) <0.001
NA: not applicable.
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were more likely to have foot surgery.
The strength of the study is the design: a prospective
longitudinal cohort with 9-year follow-up of patients and a
wide geographical area suggests that the results are rep-
resentative of secondary care in true to life settings across
England. This highlights the relative lack of podiatry:
only 29% of the cohort had ever seen a podiatrist despite
previous studies highlighting the widespread nature and
high disease burden of foot symptoms in RA [1, 2,
1416, 30].
Recent data suggest that the prevalence of foot symp-
toms is similar within the first 2 years of disease with a
point prevalence of 61.3% and a disease course preva-
lence of 90% [30]. This further supports the contention
that with only 29% of the cohort ever seeing a podiatrist,
there remains a substantial unmet need. It was also not-
able that, of the 47 patients who had surgery in the first
9 years, 28 of them had never seen a podiatrist. This may
suggest a lack of integration between foot care providers,
which is consistent with previous studies [22] and raises
questions about the timing of both conservative and sur-
gical interventions.
The importance of foot and ankle pathology in RA has
gained recognition through the recently introduced ARMA
Standards of Care for People with musculoskeletal condi-
tions and the National Institute for Health and Clinical
Excellence (NICE) guidelines for people with RA: both rec-
ommend that all people with RA and foot problems should
have access to a podiatrist [31, 32]. The results of this
study do not capture the affect of the introduction of
such guidelines nor the recent advances in pharmaco-
logical therapy. It does, however, provide important
baseline data from which to evaluate the impact of these
developments on levels of foot care in patients with RA.
Limitations of the current study are implicit in the design
of all prospective observational cohorts with long-term
follow-up: clinical practice is likely to evolve during the
study period, but data are unlikely to reflect results of
changes occurring near the end of the study period. As
such the effect of the recently introduced NICE and ARMA
guidelines are not captured, nor is the potential impact of
improved pharmacological therapy. Similarly secondary
analyses, such as this, are limited to investigating vari-
ables collected in the original data set. While it is possible
that other factors may predict future foot care, we were
not able to investigate them in the current study. However,
it must be remembered that prospective cohorts provide
robust data offering unique insights into the natural his-
tory, management and impact of disease [33]. Although
this design does have limitations it also accounts for the
study’s major strengths of prospective, multicentre data in
a large inception cohort with 9-year follow-up.
Traditionally, the literature suggests that the lack of at-
tention paid to the feet during routine clinical care is a
major contributor to low levels of foot health care. The
standard measure of disease activity [28-joint DAS
(DAS-28)] does not include any foot joints, and ever
since the development of the DAS-28 it has been
argued that in order to improve clinical care the joints of
the feet must be examined [3438]. However, the joint
count used in the ERAS cohort did include the feet and
yet levels of foot care were still very low. While this is likely
to be in part due to poor availability of foot health services,
it also suggests that foot examinations should be more
complex than merely assessing the number of tender
and swollen joints. Clinicians should have the skills
required to assess the complex soft-tissue structures in
the foot that are frequently affected in RA.
With only 4% of the cohort having foot surgery, it is
clear that its use is not widespread in the first 9 years
after disease onset. Without evidence-based guidelines
of when to escalate individual patients from conservative
to surgical care, it is not possible to say whether this
number represents adequate access to surgery or other-
wise. Nonetheless, this is the first time this information has
been reported across such a cohort and sets an important
benchmark for future comparison. Over two-thirds of foot
operations in the cohort were performed on the MTP
joints. This may reflect the extent of forefoot deformity in
RA [7, 8] along with the successful results of the forefoot
arthroplasty that has previously been shown to be the
most widely used forefoot procedure in RA [10].
From the multivariate models, it is clear that global pa-
tient factors previously linked with more severe disease
[39, 40] such as age, gender and baseline DAS, were
found to be independently associated with future conser-
vative and surgical foot care. However, these
models showed limited discriminatory ability and it is not
clear whether this observed effect is due to the small
number of patients receiving foot care or whether there
are additional factors affecting the type of foot care
received.
While there are clear benefits of knowing which patients
are likely to receive conservative or surgical foot care,
care must be taken not to confuse this with predicting
patients who will need foot care or even benefit from it.
Outcomes from conservative and surgical treatment have
been shown to vary, particularly so in surgery where the
potential for large improvements in pain and quality of life
must be weighed against the risk that patients could be
worse off [41, 42]. Much work is still needed to guide clin-
ical decision-making and treatment choice in order to
bring the era of personalized medicine to foot care: iden-
tifying patients with capacity to benefit from treatments
would be a conceptually superior approach to both
individual case management and broader service plan-
ning [43].
In conclusion, we found that fewer than one-third of pa-
tients accessed conservative foot care within the first
9 years after onset of their RA and only 4% had foot sur-
gery. Female patients with later onset of disease were
more likely to have conservative foot care, whereas
female patients with earlier disease onset were more
likely to have foot surgery. For the first time, we have iden-
tified patient-specific factors associated with subsequent
conservative and surgical foot care. Despite the known
high prevalence of foot symptoms and the increasing
www.rheumatology.oxfordjournals.org 1593
Use of conservative and surgical foot care in RAevidence of their impact on patients, there remains a sub-
stantial unmet need for foot care in patients with RA.
Rheumatology key messages
. Fewer than one-third of patients had accessed po-
diatry 9 years after disease onset, representing a
large unmet need.
. Older females were more likely to have conserva-
tive care, whereas younger females were more
likely to have surgery.
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